Depressive Clinical Trials

1 recruiting

Frequently Asked Questions

Common questions about Depressive clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 501 trials

Recruiting
Phase 2

Study of Neuro-Cognitive Correlates of Pediatric Anxiety Disorders

Major Depressive DisorderAnxiety Disorders
National Institute of Mental Health (NIMH)2,530 enrolled1 locationNCT00018057
Recruiting
Phase 3

A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder

DepressionDepression - Major Depressive DisorderDepression in Adults+3 more
Cybin IRL Limited330 enrolled67 locationsNCT06793397
Recruiting
Not Applicable

rTMS for Depression in Young Adults With Autism

Autism Spectrum DisorderMajor Depressive Disorder
Centre for Addiction and Mental Health80 enrolled1 locationNCT04972136
Recruiting
Phase 3

A Study to Evaluate the Maintenance Effect of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)

Major Depressive Disorder
Neurocrine Biosciences550 enrolled45 locationsNCT07196501
Recruiting
Phase 2

A Clinical Trial of Add-on Oral Slow-release Ketamine Treatment in Major Depression

Major Depressive Disorder (MDD)
Daniel Lindqvist12 enrolled1 locationNCT07396272
Recruiting
Not Applicable

IMST for Dementia Risk Reduction

Sleep QualityCognitive FunctionBlood Pressure+4 more
Florida State University30 enrolled1 locationNCT07349706
Recruiting
Phase 2

A Study to Evaluate the Effectiveness of DT-101 in Patients With Depression

Major Depressive Disorder (MDD)
Draig Therapeutics Ltd300 enrolled24 locationsNCT07300969
Recruiting
Phase 2

A Study to Assess Change in Disease Activity and Adverse Events of Oral Icalcaprant in Adult Participants With Major Depressive Disorder

Major Depressive Disorder
AbbVie195 enrolled31 locationsNCT07276997
Recruiting
Not Applicable

Moving on After Breast Cancer Trial for Depressed Breast Cancer Survivors in Pakistan

Breast Cancer SurvivorMajor Depressive Disorder (MDD)
Pakistan Institute of Living and Learning26,376 enrolled1 locationNCT07015944
Recruiting
Not Applicable

Dopamine Modulation of Motivation and Motor Function in Major Depression & Inflammation

Depressive Disorder, Major
Charite University, Berlin, Germany165 enrolled1 locationNCT05909267
Recruiting
Phase 4

TDM-Guided Treatment With SSRIs in Hospitalized Adults and Children

Depression - Major Depressive DisorderDepressive Episodes
Poznan University of Medical Sciences180 enrolled1 locationNCT07478796
Recruiting

Biomarker Research on Ultra-High-Field MRI Combined With Visual Perception Assessment in the Diagnosis and Treatment Outcomes of Severe Mental Disorders

SchizophreniaMajor Depressive Disorder (MDD)Bipolar Disorder+1 more
Second Affiliated Hospital, School of Medicine, Zhejiang University320 enrolled1 locationNCT07479758
Recruiting
Not Applicable

Defining Neurobiological Links Between Substance Use and Mental Illness

Substance Use DisorderNormal PhysiologyMajor Depressive Disorder
National Institute on Drug Abuse (NIDA)620 enrolled1 locationNCT05538910
Recruiting
Phase 3

Phase 3 Study of Adjunctive Treatment With Seltorexant in Adult and Elderly Participants With Major Depressive Disorder and Insomnia Symptoms

Depressive Disorder, Major
Janssen Research & Development, LLC752 enrolled200 locationsNCT06559306
Recruiting

A Study to Evaluate Sleep Electroencephalogram (EEG) Features (Brain Activity While Sleeping) in Participants With Major Depressive Disorder (MDD)

Depressive Disorder, Major
Janssen Research & Development, LLC80 enrolled14 locationsNCT07258485
Recruiting
Phase 2

A Study to Explore the Efficacy of JNJ-89495120 in the Treatment of Major Depressive Disorder

Depressive Disorder, Major
Janssen Research & Development, LLC124 enrolled43 locationsNCT06785012
Recruiting
Early Phase 1

Psilocybin for Depression in People With Mild Cognitive Impairment or Early Alzheimer's Disease

DepressionDepressive SymptomsAlzheimer Disease+1 more
Johns Hopkins University20 enrolled1 locationNCT04123314
Recruiting
Phase 4

A Study of Esketamine Nasal Spray in Korean Participants With Treatment-resistant Depression

Depressive Disorder, Treatment-Resistant
Janssen Korea, Ltd., Korea47 enrolled6 locationsNCT07053345
Recruiting
Phase 3

A Study to Evaluate the Efficacy and Safety of Esketamine for Reduction of Symptoms of Major Depressive Disorder

Depressive Disorder, Major
Janssen Research & Development, LLC258 enrolled2 locationsNCT07227454
Recruiting
Phase 2

ACP-211 Monotherapy for Major Depressive Disorder With Inadequate Antidepressant Response

Major Depressive Disorder (MDD)Depressive Disorder, Treatment-Resistant
ACADIA Pharmaceuticals Inc.153 enrolled12 locationsNCT07284667